Labcorp launches convenient home diagnostic test collection service in collaboration with Getlabs

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 22, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of Getlabs for Labcorp, an innovative health care service that combines Labcorp’s diagnostic tests with Getlabs phlebotomy service to conveniently test consumers in the comfort of their own homes.

Labcorp enhances cell and gene therapy development support through collaboration with Xcell Biosciences

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 19, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, is collaborating with Xcell Biosciences, Inc. (Xcellbio), a leading developer of cell and gene therapy technologies, to advance critical work that helps clients effectively bring innovative cell and gene therapies to market.

Needs Beyond Medicine receives $10,000 grant from The Labcorp Charitable Foundation

SALT LAKE CITY, Utah, April 6, 2022 — Needs Beyond Medicine today announced the receipt of a $10,000 grant from The Labcorp Charitable Foundation in support of its Relief Program, which brings critical assistance to adults with cancer who are facing the fight of their lives.